The Power of Self-Injectable Contraception

Thanks to their government, more Malawian women than ever have access to the contraception they deserve.

From 2015 to 2017, the Ministry of Health and Population of Malawi worked with the University of Malawi and FHI360 to investigate the effectiveness of self-administered depot medroxyprogesterone acetate (DMPA-SC). The study, funded by the Children’s Investment Fund Foundation (CIFF) and USAID,  found that self-injection with DMPA-SC led to a more than 50% increase in continuous pregnancy protection over 12 months, compared to provider-administered injection. As a result of the study findings, the Ministry of Health in Malawi is now rolling out DMPA-SC and self-injection in 7 districts across the country, with plans for national scale-up by 2020.

Watch this video to learn more about how this research turned into practice for self-injectable contraception in Malawi.

Want to learn more about Malawi’s path to contraceptive self-injection? Check out our op-ed from Dr. Fannie Kachale, Director of the Reproductive Health Department the Ministry of Health and Population of Malawi.

Banner image: (c)PSI/Emma Beck

Sign up to
Receive Updates

Donate to
Support Our Work